The cut-off value (UCP CRP level at the time of delivery: 200 ng/mL) of FIRS was originally chosen to optimally identify EONS in preterm neonates, nearly half of which were born to mothers with acute-HCA in previous study [21]. Here, CRP is linked to hepatocellular adenoma.